ALT5 Sigma Reports 99% Year-Over-Year Increase in Transaction Volume to Over US $879 Million for First Two Quarters of 2024
ALT5 Sigma (NASDAQ:ALTS) reported a 99% year-over-year increase in transaction volume to over US $879 million for the first two quarters of 2024. The company's June 2024 transaction volume reached approximately US$124 million, a 68% increase compared to the same period in 2023. ALT5 Sigma, a fintech company providing blockchain-powered technologies for digital asset management, attributes this growth to increasing digital asset adoption, particularly in the institutional market.
The company offers two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform. In 2023, ALT5 Sigma processed over US$1.2 billion in cryptocurrency transactions. The company is also involved in biotech activities, focusing on developing innovative solutions to address the opioid crisis.
ALT5 Sigma (NASDAQ:ALTS) ha riportato un aumento del 99% anno su anno del volume delle transazioni, superando i 879 milioni di dollari USA per i primi due trimestri del 2024. Il volume delle transazioni di giugno 2024 ha raggiunto circa 124 milioni di dollari USA, con un incremento del 68% rispetto allo stesso periodo del 2023. ALT5 Sigma, una azienda fintech che offre tecnologie basate su blockchain per la gestione degli asset digitali, attribuisce questa crescita all’aumento dell’adozione degli asset digitali, in particolare nel mercato istituzionale.
L'azienda offre due piattaforme principali: ALT5 Pay, un gateway di pagamento in criptovaluta, e ALT5 Prime, una piattaforma di trading elettronico over-the-counter. Nel 2023, ALT5 Sigma ha elaborato oltre 1,2 miliardi di dollari USA in transazioni di criptovaluta. L’azienda è anche coinvolta in attività biotecnologiche, concentrandosi nello sviluppo di soluzioni innovative per affrontare la crisi degli oppioidi.
ALT5 Sigma (NASDAQ:ALTS) reportó un aumento del 99% en el volumen de transacciones año tras año, superando los 879 millones de dólares estadounidenses en los primeros dos trimestres de 2024. El volumen de transacciones de junio de 2024 alcanzó aproximadamente 124 millones de dólares estadounidenses, un incremento del 68% en comparación con el mismo periodo de 2023. ALT5 Sigma, una empresa fintech que proporciona tecnologías impulsadas por blockchain para la gestión de activos digitales, atribuye este crecimiento a la creciente adopción de activos digitales, particularmente en el mercado institucional.
La empresa ofrece dos plataformas principales: ALT5 Pay, una pasarela de pago de criptomonedas, y ALT5 Prime, una plataforma de trading electrónico over-the-counter. En 2023, ALT5 Sigma procesó más de 1.2 mil millones de dólares en transacciones de criptomonedas. La empresa también está involucrada en actividades biotecnológicas, enfocándose en desarrollar soluciones innovadoras para abordar la crisis de los opioides.
ALT5 시그마 (NASDAQ:ALTS)는 2024년 첫 두 분기 동안 거래량이 전년 대비 99% 증가하여 8억 7900만 달러를 초과했다고 보고했습니다. 2024년 6월의 거래량은 약 1억 2400만 달러로, 2023년 같은 기간과 비교하여 68% 증가했습니다. 블록체인 기술을 활용한 디지털 자산 관리 솔루션을 제공하는 핀테크 기업인 ALT5 시그마는 이 성장을 특히 기관 시장에서의 디지털 자산 채택 증가 때문으로 보고 있습니다.
회사는 두 가지 주요 플랫폼인 ALT5 Pay (암호화폐 결제 게이트웨이)와 ALT5 Prime (전자 장외 거래 플랫폼)을 제공합니다. 2023년 ALT5 시그마는 12억 달러 이상의 암호화폐 거래를 처리했습니다. 또한 이 회사는 오피오이드 위기를 해결하기 위한 혁신적인 솔루션 개발에 초점을 맞춘 생명공학 활동에 참여하고 있습니다.
ALT5 Sigma (NASDAQ:ALTS) a annoncé un augmentation de 99% du volume des transactions d'une année sur l'autre, dépassant les 879 millions de dollars américains pour les deux premiers trimestres de 2024. Le volume des transactions de l’entreprise en juin 2024 a atteint environ 124 millions de dollars américains, soit une augmentation de 68% par rapport à la même période en 2023. ALT5 Sigma, une entreprise fintech fournissant des technologies basées sur la blockchain pour la gestion des actifs numériques, attribue cette croissance à l'augmentation de l'adoption des actifs numériques, en particulier sur le marché institutionnel.
L’entreprise propose deux principales plateformes : ALT5 Pay, une passerelle de paiement en cryptomonnaie, et ALT5 Prime, une plateforme de trading électronique de gré à gré. En 2023, ALT5 Sigma a traité plus de 1,2 milliard de dollars en transactions de cryptomonnaies. L'entreprise est également impliquée dans des activités biopharmaceutiques, se concentrant sur le développement de solutions innovantes pour faire face à la crise des opioïdes.
ALT5 Sigma (NASDAQ:ALTS) berichtete von einem 99%-igen Anstieg des Transaktionsvolumens im Vergleich zum Vorjahr auf über 879 Millionen US-Dollar in den ersten beiden Quartalen von 2024. Das Transaktionsvolumen des Unternehmens im Juni 2024 belief sich auf etwa 124 Millionen US-Dollar, was einem Anstieg von 68% im Vergleich zum gleichen Zeitraum 2023 entspricht. ALT5 Sigma, ein Fintech-Unternehmen, das blockchain-gestützte Technologien für das Management digitaler Vermögenswerte anbietet, führt dieses Wachstum auf die steigende Akzeptanz digitaler Vermögenswerte, insbesondere im institutionellen Markt, zurück.
Das Unternehmen bietet zwei Hauptplattformen an: ALT5 Pay, ein Kryptowährungs-Zahlungsgateway, und ALT5 Prime, eine elektronische Plattform für den außerbörslichen Handel. Im Jahr 2023 verarbeitete ALT5 Sigma Transaktionen im Wert von über 1,2 Milliarden US-Dollar in Kryptowährungen. Das Unternehmen ist auch in biotechnologischen Aktivitäten tätig und konzentriert sich darauf, innovative Lösungen zur Bekämpfung der Opioidkrise zu entwickeln.
- 99% year-over-year increase in transaction volume to US $879 million for Q1 and Q2 2024
- 68% year-over-year increase in June 2024 transaction volume to US$124 million
- Processed over US$1.2 billion in cryptocurrency transactions in 2023
- Inclusion in the Russell Microcap Index as of June 28, 2024
- None.
Insights
ALT5 Sigma's reported 99% year-over-year increase in transaction volume to over
However, it's important to note that transaction volume doesn't directly translate to revenue or profitability. Investors should seek clarity on the company's fee structure and profit margins to better understand how this volume growth impacts the bottom line. Additionally, while the growth is impressive, the absolute volume of
The company's dual focus on fintech and healthcare, particularly its efforts in addressing the opioid crisis, presents a unique value proposition but also potential risks in terms of resource allocation and management focus. Investors should monitor how effectively the company balances these disparate business lines and whether synergies emerge between them.
ALT5 Sigma's blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets position the company at the forefront of the evolving financial technology landscape. The company's two main platforms, ALT5 Pay and ALT5 Prime, address critical needs in the cryptocurrency ecosystem:
- ALT5 Pay offers a crypto payment gateway, enabling merchants to accept and make cryptocurrency payments.
- ALT5 Prime provides an over-the-counter trading platform for digital assets.
The integration capabilities with WooCommerce and the availability of APIs suggest a focus on developer-friendly solutions, which could drive adoption among merchants and financial institutions. The mobile app 'ALT5 Pro' and integration with Broadridge Financial Solutions' NYFIX gateway further expand accessibility.
However, the competitive landscape in crypto payment and trading solutions is intensifying. Giants like PayPal and Square are entering the space and numerous fintech startups are vying for market share. ALT5 Sigma will need to continuously innovate and differentiate its offerings to maintain its growth trajectory. The company's ability to process over
The surge in ALT5 Sigma's transaction volume aligns with broader market trends in digital asset adoption. The reported increase in cryptocurrency ownership among U.S. adults from
Notably, the Deloitte survey highlighting the trajectory toward broad adoption of digital currency payment solutions among U.S. retail organizations underscores the potential for ALT5 Sigma's merchant-focused offerings. This trend could drive demand for services like ALT5 Pay, especially as more businesses seek to integrate cryptocurrency payments into their operations.
However, it's important to consider the volatility and regulatory uncertainties in the cryptocurrency market. While institutional adoption is growing, as noted by the company's Chief Revenue Officer, regulatory changes or market downturns could impact transaction volumes and adoption rates.
The company's inclusion in the Russell Microcap Index as of June 28, 2024, may increase its visibility to investors and potentially improve liquidity. However, investors should be aware that microcap stocks often come with higher volatility and risk.
ALT5 Sigma's unique positioning as both a fintech and healthcare company presents opportunities for diversification but also challenges in terms of focus and resource allocation. The success of this dual strategy will depend on the company's ability to execute effectively in both sectors and potentially find synergies between them.
LAS VEGAS, NV / ACCESSWIRE / July 25, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, released its transaction volume for Q1 and Q2 2024 combined.
According to the company, ALT5's transaction volume reached US
Cryptocurrency ownership rates amongst American adults has increased from
"Growth of digital assets adoption continues, driven to an extent by the Institutional market's adoption of digital assets," said Vay Tham, Chief Revenue Officer of ALT5 Sigma Corporation. "Our technologies, and services, provide concrete solutions for institutions and merchants in making or receiving faster and safer global payments using digital assets without having to worry about market volatility. The ALT5 platform continues to provide customers with leading solutions, as can be evidenced by our growing transaction volumes," further added Mr. Tham.
About ALT5 Sigma
The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.
Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US
ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.
ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.
Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.
Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.
Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.
Media Contact Investor Relations
IR@alt5sigma.com
1-800-400-2247
SOURCE: ALT5 Sigma Corp
View the original press release on accesswire.com
FAQ
What was ALT5 Sigma's (ALTS) transaction volume for Q1 and Q2 2024?
How much did ALT5 Sigma's (ALTS) transaction volume increase in June 2024?
What are the main platforms offered by ALT5 Sigma (ALTS)?
How much in cryptocurrency transactions did ALT5 Sigma (ALTS) process in 2023?
